Fujifilm Partners with Us2.ai to Provide AI-Automated Echocardiography Analysis for Cardiologists
What You Should Know: – FUJIFILM Healthcare, a provider of diagnostic and enterprise imaging solutions, has announced a strategic partnership with Us2.ai, a pioneer in AI-automated echocardiography solutions. – The collaboration aims to integrate Us2.ai’s artificial intelligence (AI)-driven, automated clinical workflow solution into Fujifilm’s LISENDO 880 cardiovascular ultrasound system, revolutionizing cardiac diagnostics. – The integration ... Read More


What You Should Know:
– FUJIFILM Healthcare, a provider of diagnostic and enterprise imaging solutions, has announced a strategic partnership with Us2.ai, a pioneer in AI-automated echocardiography solutions.
– The collaboration aims to integrate Us2.ai’s artificial intelligence (AI)-driven, automated clinical workflow solution into Fujifilm’s LISENDO 880 cardiovascular ultrasound system, revolutionizing cardiac diagnostics.
– The integration of Us2.ai’s software with the LISENDO 880 ultrasound system will enable fully automated analysis and reporting of echocardiograms, providing comprehensive cardiac measurements crucial for the diagnosis of heart disease.
Cardiovascular Disease Impact
Cardiovascular disease (CVD), the leading cause of mortality worldwide, relies heavily on echocardiography for non-invasive heart imaging. While echocardiography is considered safe, reliable, and cost-effective, it is also a highly manual and time-consuming procedure, requiring expert operators who are currently in short supply, contributing to sonographer workforce shortages.
Us2.ai’s echocardiographic analysis software addresses this critical challenge. Studies published in the Journal of Echocardiography have demonstrated that Us2.ai’s technology can reduce measurement and report creation time by up to 70% compared to manual methods.
Traditional echocardiography workflows involve image capture followed by manual or semi-automated measurements before data is sent to an image server. Us2.ai’s software streamlines this process by automatically analyzing images acquired on the LISENDO 880 ultrasound system, eliminating the need for manual measurements. The AI identifies heart chambers, calculates clinically significant measurements, and provides disease indication conclusions based on international guidelines for physician decision support.
“Echo images are the gold standard for non-invasive cardiac imaging, however the average time to complete an exam can take anywhere from 40 to 90 minutes, plus reporting time. AI has the ability to dramatically reduce this time burden, provide cardiologists with intelligent insights, and allow for more patients to get scanned,” said Hideyuki Honda, Vice President, Ultrasound Business Unit and Business Development, FUJIFILM Healthcare Americas Corporation. “Fujifilm is thrilled to partner with Us2.ai to integrate their sophisticated AI with our cutting-edge LISENDO 880, providing cardiologists with exceptional, AI-driven automation analysis of the heart.”